ArticleThe pharmacogenomics journal2017
Determinants of Gefitinib toxicity in advanced non-small cell lung cancer (NSCLC): a pharmacogenomic study of metabolic enzymes and transporters.
Y Ma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it